Naveris to Highlight New Publications at the 44th Annual J.P. Morgan Healthcare Conference Press Release Naveris to Highlight New Publications at the 44th Annual J.P. Morgan Healthcare Conference
Naveris Announces Expanded Medicare Coverage for the NavDx® Test in Identification of Molecular Residual Disease of Anal Squamous Cell Carcinoma Press Release Naveris Announces Expanded Medicare Coverage for the NavDx® Test in Identification of Molecular Residual Disease of Anal Squamous Cell Carcinoma
